PubRank

A Antela

Author PubWeight™ 26.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Tuberculous meningitis caused by resistant microorganisms. Therapeuticfailure in 2 patients with HIV infection and disseminated tuberculosis]. Enferm Infecc Microbiol Clin 1994 1.38
2 [Systemic mastocytosis and explorative laparotomy]. Rev Clin Esp 1991 1.38
3 [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]. Enferm Infecc Microbiol Clin 2000 1.38
4 Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. AIDS 1998 1.12
5 [Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology]. Med Clin (Barc) 1998 1.05
6 [The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers]. Enferm Infecc Microbiol Clin 2000 0.93
7 Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy. Eur J Clin Microbiol Infect Dis 2001 0.86
8 Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients. Antivir Ther 1999 0.86
9 Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease. AIDS 1997 0.85
10 Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure. AIDS Res Hum Retroviruses 2001 0.84
11 Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes. AIDS 2001 0.84
12 Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen. HIV Med 2014 0.83
13 Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors. J Acquir Immune Defic Syndr Hum Retrovirol 1998 0.82
14 Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy. Am J Kidney Dis 1996 0.82
15 Phenotypic testing predicts virological response in successive protease inhibitor-based regimens. AIDS 2000 0.82
16 A clinical study of the combination of 100 mg ritonavir plus 800 mg indinavir as salvage therapy: influence of increased plasma drug levels in the rate of response. HIV Clin Trials 2001 0.79
17 Once-daily antiretroviral therapy: Spanish Consensus Statement. J Antimicrob Chemother 2005 0.79
18 Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus. J Viral Hepat 2006 0.78
19 Community acquired pneumonia caused by Chlamydia pneumoniae strain TWAR in chronic cardiopulmonary disease in the elderly. Respiration 1991 0.77
20 Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene. AIDS Res Hum Retroviruses 2001 0.77
21 Access to antiretroviral therapy in HIV-infected injection drug users. AIDS 2001 0.77
22 Acute mediastinitis due to Rhodococcus equi in a patient with human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis 1997 0.77
23 Effectiveness and pitfalls of initial highly active antiretroviral therapy in HIV-infected patients in routine clinical practice. Antivir Ther 2000 0.76
24 Limitations of a simplification antiretroviral strategy for HIV-infected patients with decreasing adherence to a protease inhibitor regimen. HIV Clin Trials 2006 0.76
25 Failure of a ritonavir plus saquinavir-based rescue regimen precludes the use of protease inhibitors. AIDS 2000 0.76
26 Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status. HIV Clin Trials 2011 0.76
27 Risk factors for ritonavir intolerance and outcome after change to indinavir. AIDS 1998 0.75
28 [Epidemiology of infection by Chlamydia pneumoniae in Spain]. Enferm Infecc Microbiol Clin 1991 0.75
29 [Clindamycin desensitization in a patient with the acquired immunodeficiency syndrome]. Med Clin (Barc) 1992 0.75
30 Retinal toxicity associated with didanosine in HIV-infected adults. AIDS 1996 0.75
31 [GESIDA Consensus document on the use of resistance studies in clinical practice]. Enferm Infecc Microbiol Clin 2001 0.75
32 Patients failing saquinavir therapy require an early change to indinavir before HIV-1 viral load reaches high levels. Antivir Ther 1999 0.75
33 [Aortoenteric fistula. A severe disorder with difficult diagnosis]. Enferm Infecc Microbiol Clin 1992 0.75
34 [Colon-splenic fistula. Complicated by large cell non-Hodgkin's lymphoma]. Rev Esp Enferm Apar Dig 1988 0.75
35 [Pneumocystis carinii pneumonia and spontaneous pneumothorax]. An Med Interna 1991 0.75
36 [Arthritis and tenosynovitis caused by Mycobacterium kansasii associated with human immunodeficiency virus infection]. Rev Clin Esp 1999 0.75
37 Central venous catheter infections in AIDS patients receiving daily home therapy for cytomegalovirus disease. QJM 1996 0.75
38 [Are DNA probes useful for the diagnosis of Mycoplasma++ pneumoniae pneumonia?]. Med Clin (Barc) 1992 0.75
39 [Pneumocystis carinii recurrence after the use of prophylactic inhaled pentamidine. The unusual radiological findings]. Med Clin (Barc) 1991 0.75
40 Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co-infection. Transpl Infect Dis 2011 0.75
41 [Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)]. Enferm Infecc Microbiol Clin 1998 0.75
42 Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study. HIV Med 2008 0.75
43 [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)]. Enferm Infecc Microbiol Clin 2000 0.75